BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Stem cell
,
Early pregnancy factor
,
Ciprofibrate
,
rs2476601
,
FGF21
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
kelch-like
Summary
General Info
Curated Studies
Most Correlated Studies
Hepatocellular carcinoma Hep 3B and HuH-7 cells with KLHL23 shRNA knockdown
Livers of mice with conditional KEAP1 siRNA knockdown
Livers of mice with Nfe2l2 (Nrf2) knockout, Keap1 hepatocyte-specific knockout, or Keap1 knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
A KLHL40 3' UTR splice-altering variant causes milder NEM8, an under-appreciated disease mechanism.
Didymin protects against polystyrene nanoplastic-induced hepatic damage in male albino rats by modul…
Mesenchymal stem cells-derived exosomal miR-24-3p ameliorates non-alcohol fatty liver disease by tar…
KLHL22 promotes malignant melanoma growth in vitro and in vivo by activating the PI3K/Akt/mTOR signa…
Correlations of ALD, Keap-1, and FoxO4 expression with traditional tumor markers and clinicopatholog…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tecfidera Diffusion Tensor Imaging
Muscle Wasting in Cancer (MWIC)
Broccoli Sprout Extracts Trial to See if NRF2 is Enhanced by Sulforaphane Treatment in Patients With…
ERASE - Impact of COVID-19 on Malaria Control
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ